MobiHealth News March 8, 2021
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive adjustments from their provider via a cellular or WiFi connection.
The NeuroSphere Virtual Clinic was recently approved by the FDA and is now available within the Abbott patient controller app for use with Abbott’s Infinity DBS System for Parkinson’s disease or essential tremor, the Proclaim XR SCS System for chronic pain and the Proclaim DRG Neurostimulation System for chronic pain in lower limbs due to...
Today's Sponsors
Today's Sponsor